FindTrial
Sign In

Use of Acupuncture in the treatment of Dry Mouth and Oral Wounds caused by treatment in patients with head and neck Cancer

Use of Low-power Laser Therapy and Acupuncture in the treatment of radio-induced Mucositis and Radiodermatitis in patients with head and neck Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-69fnqt
Enrollment
Unknown
Registered
2017-12-21
Start date
2017-03-01
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Xerostomia. mucositis

Interventions

This is a randomized, controlled, parallel-group clinical study with simple randomization performed by computer-generated allocation in a 1:1 ratio, without masking of participants or researchers. Dur

Sponsors

Universidade Estadual de Montes Claros
Lead Sponsor
Universidade Estadual de Montes Claros
Collaborator

Eligibility

Age
20 Years to No maximum

Inclusion criteria

Inclusion criteria: Histopathological diagnosis confirmed squamous cell carcinoma of the head and neck; Age over 20 years of age; In need of radiotherapy treatment; both sexes; Agree to participate in the study

Exclusion criteria

Exclusion criteria: Individuals who do not have capacity or have limitations that prevent them from responding to the questionnaires

Design outcomes

Primary

MeasureTime frame
Primary outcome expected reduction in mucositis after treating the patient with the combination of red and infrared laser;Outcome found: A 22.6% reduction in mucositis levels was observed in patients who used the combination of red and infrared laser, compared to those who used only the red laser—

Secondary

MeasureTime frame
No secondary results are expected—

Countries

Brazil

Contacts

Public ContactAndré Guimarães

Universidade Estadual de Montes Claros

andreluizguimaraes@gmail.com+55(38)988313705

Outcome results

None listed

Source: REBEC (via WHO ICTRP)